At the time of writing, Pulmonx Corp [LUNG] stock is trading at $1.77, up 5.99%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The LUNG shares have gain 15.69% over the last week, with a monthly amount drifted -42.72%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Pulmonx Corp [NASDAQ: LUNG] stock has seen the most recent analyst activity on July 31, 2025, when Piper Sandler downgraded its rating to a Neutral but kept the price target unchanged to $2.50 for it. Previously, D. Boral Capital started tracking the stock with Buy rating on March 10, 2025, and set its price target to $17. On December 11, 2024, downgrade downgraded it’s rating to Neutral and revised its price target to $7.50 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $12 on June 04, 2024. Wells Fargo downgraded its rating to a Equal Weight and reduced its price target to $14 on February 23, 2024. Craig Hallum started tracking with a Buy rating for this stock on September 05, 2023, and assigned it a price target of $18. In a note dated February 27, 2023, Wells Fargo upgraded an Overweight rating on this stock and boosted its target price from $10 to $15.
For the past year, the stock price of Pulmonx Corp fluctuated between $1.47 and $9.37. Currently, Wall Street analysts expect the stock to reach $2.5 within the next 12 months. Pulmonx Corp [NASDAQ: LUNG] shares were valued at $1.77 at the most recent close of the market. An investor can expect a potential return of 41.24% based on the average LUNG price forecast.
Analyzing the LUNG fundamentals
According to Pulmonx Corp [NASDAQ:LUNG], the company’s sales were 90.55M for trailing twelve months, which represents an 14.80% jump. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.65%, Pretax Profit Margin comes in at -0.62%, and Net Profit Margin reading is -0.63%. To continue investigating profitability, this company’s Return on Assets is posted at -0.39, Equity is -0.7 and Total Capital is -0.47. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.82.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6667 points at the first support level, and at 1.5633 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.8267, and for the 2nd resistance point, it is at 1.8833.
Ratios To Look Out For
It is important to note that Pulmonx Corp [NASDAQ:LUNG] has a current ratio of 5.34. Also, the Quick Ratio is 4.62, while the Cash Ratio stands at 3.36. Considering the valuation of this stock, the price to sales ratio is 0.80, the price to book ratio is 1.04.
Transactions by insiders
Recent insider trading involved Ferrari Richard, Director, that happened on Jun 12 ’25 when 8000.0 shares were sold. Director, Ferrari Richard completed a deal on Jun 13 ’25 to buy 5438.0 shares. Meanwhile, Director RICH FERRARI bought 8000.0 shares on Jun 12 ’25.
